<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bom, J.G. van der</title>
    <link>http://repub.eur.nl/res/aut/1927/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Gynaecological and obstetric bleeding in moderate and severe von willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/33818/</link>
      <pubDate>2011-11-01T00:00:00Z</pubDate>
      <description>A nation-wide cross-sectional study was initiated to assess gynaecological and obstetrical symptoms in an unselected cohort of women with moderate and severe von Willebrand disease (VWD) in the Netherlands. A total of 423 women aged ≥16 years were included. Bleeding severity was measured using the Tosetto Bleeding Score (BS). Menorrhagia, defined as occurrence of ≥2 menorrhagia symptoms, was reported by 81%. Of all VWD women, 78% received any kind of treatment for menorrhagia and 20% underwent a hysterectomy predominantly because of severe menstrual bleeding. Over half of the women reported more blood loss than can be expected with a normal delivery. In 52% of reported pregnancy losses curettage was needed because of bleeding. Mean number of live births was 1.9, which is comparable with the general Dutch population. In conclusion, women with moderate or severe VWD frequently have menorrhagia in need of treatment, and 20% of the VWD women underwent a hysterectomy. Bleeding complications occurred in over 50% of the women after childbirth or pregnancy loss. Progeny seems not to be affected in women with moderate or severe VWD. </description>
    </item> <item>
      <title>Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/30717/</link>
      <pubDate>2011-10-06T00:00:00Z</pubDate>
      <description>Patients with von Willebrand disease (VWD), the most common inherited bleeding disorder, display large variation in bleeding tendency, which is not completely related to VWF levels. The cause of variability in clinical expression is largely unknown. The effect of plasma fibrinolytic capacity on bleeding tendency in VWD patients has not been investigated. We hypothesized that enhanced fibrinolysis may result in a more severe bleeding phenotype. Therefore, we measured the fibrinolytic potential in patients with moderate or severe VWD to investigate the contribution of fibrinolysis to the bleeding tendency. Fibrinolytic potential was measured as plasma clot lysis time (CLT) with and without addition of potato carboxypeptidase inhibitor (PCI) in 638 patients with moderate or severe VWD who participated in a nationwide multicentre cross-sectional study. Bleeding severity was measured using the Bleeding Score (BS).The CLTs were significantly longer, indicative of hypofibrinolysis, in men compared to women with VWD [106.2 (IQR 95.7-118.1) vs. 101.9 (IQR 92.8-114.0) min]. The CLTs prolonged with increasing age. No association was found between VWF or FVIII levels and CLT, or between VWF or FVIII levels and CLT+PCI. No association was observed for BS in a model with 10log-transformed CLT, adjusted for age, gender, VWF:Act and FVIII [b=6.5 (95%CI -0.3 to 13.4)]. Our study showed that the plasma fibrinolytic potential does not influence bleeding tendency in VWD patients and therefore does not explain the variability in bleeding phenotype in VWD. </description>
    </item> <item>
      <title>Impact of von Willebrand disease on health-related quality of life in a pediatric population (Article)</title>
      <link>http://repub.eur.nl/res/pub/23850/</link>
      <pubDate>2011-03-01T00:00:00Z</pubDate>
      <description>Background: Von Willebrand disease (VWD) is the most frequent inherited bleeding disorder. Whether VWD is associated with health-related quality of life (HR-QoL) in children is unknown. Objectives: This nationwide cross-sectional study measured HR-QoL in children with moderate or severe VWD. Our primary aim was to compare HR-QoL of VWD patients with that of reference populations. Additionally, we studied the impact of bleeding phenotype and VWD type on HR-QoL. Methods: HR-QoL was assessed with the Infant/Toddler QoL Questionnaire (0-5 years) and Child Health Questionnaire (6-15 years), and compared with reference population scores. Multivariate analysis was used to evaluate the influence of type of VWD and bleeding phenotype on HR-QoL scores. Results: Preschool children (0-5 years, n=46) with VWD had lower HR-QoL scores for general health perceptions and parental time than reference populations. School children (6-15 years, n=87) with VWD had lower scores for physical functioning, role functioning - emotional/behavioral, general health perceptions, and physical summary. Type of VWD was associated with HR-QoL in school children for bodily pain, general health perceptions, parental emotion, family activities, and physical summary. Scores of children with type 3 VWD were, on average, 15 points lower than those of the reference population on the above-mentioned scales. A more severe bleeding phenotype was associated with a lower score on 11/15 physical, emotional and social scales. Conclusion: HR-QoL is lower in VWD children than in reference populations, in particular in school children. The negative impact of VWD is sensitive to type of VWD and bleeding phenotype; as well as physical scales, emotional and social scales are affected. </description>
    </item> <item>
      <title>Health-related quality of life among adult patients with moderate and severe von Willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/28549/</link>
      <pubDate>2010-07-01T00:00:00Z</pubDate>
      <description>Background: von Willebrand Disease (VWD) is the most frequent inherited bleeding disorder. It is unknown how this disorder affects quality of life. Objectives: This nationwide multicenter cross-sectional study determined health-related quality of life (HR-QoL) in adult patients with moderate or severe VWD, and assessed whether bleeding severity and type of VWD are associated with HR-QoL. Methods: HR-QoL was assessed using the Short Form (SF)-36, and bleeding severity was measured using the Bleeding Score (BS). Results: Five hundred and nine patients participated; 192 males and 317 females, median age and range 45 (16-87) and 47 (16-84) years, respectively. Compared with the general population, HR-QoL in VWD patients was lower in the vitality domain (61 vs. 66 P &lt; 0.001 for females, 67 vs. 72 P &lt; 0.001 for males). Patients with the most severe bleeding phenotype (highest quartile BS, BS &gt; 17) had a lower HR-QoL in eight domains than patients with a less severe bleeding type (lowest quartile BS, BS &lt; 7) in the univariate analysis. After adjustment for age, gender, co-morbidity and employment/educational status, a more severe bleeding phenotype was associated with lower scores on the domains of physical functioning, role limitations due to physical functioning, bodily pain, general health, social functioning and physical component summary. Conclusions: HR-QoL is lower in VWD patients compared with the general population. HR-QoL is strongly associated with bleeding phenotype. </description>
    </item> <item>
      <title>Social participation of patients with hemophilia in the Netherlands (Article)</title>
      <link>http://repub.eur.nl/res/pub/29058/</link>
      <pubDate>2008-02-15T00:00:00Z</pubDate>
      <description>The introduction of replacement therapy in the 1960s has improved medical and social circumstances gradually. The availability of prophylactic treatment has further increased the possibilities of a "normal" life for patients with hemophilia. We examined whether social participation and health-related quality of life (HRQol) of today's hemophilia patients differs from the general male population. There were a total of 721 participants in the Hemophilia in the Netherlands 5 study (HiN-5 study) ages 16 to 64 years. Patients with severe hemophilia participated less in full-time work compared with the general population. Occupational disability was reported by 35% of patients with severe hemophilia between ages 31 and 64 years, compared with 9% in the general population. HRQol of patients with severe hemophilia between ages 31 and 64 years was lower than of the general population. The differences with the general population in HRQol were least pronounced for patients between ages 16 and 30 years. Despite major improvements in treatment during the last decades, patients with hemophilia are still less involved in full-time paid work and suffer more from occupational disability than men from the general population. After the introduction of prophylactic treatment, the number of patients who are occupationally disabled is reduced. </description>
    </item> <item>
      <title>Elevated plasma fibrinogen: cause or consequence of cardiovascular disease? (Article)</title>
      <link>http://repub.eur.nl/res/pub/8806/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>An association between increased plasma fibrinogen and an increased risk
          for myocardial infarction (MI) is well established, but the nature of this
          association is subject to debate. Our aim was to shed light on the
          potentially causal nature of this association. We examined whether
          increased plasma fibrinogen, due to a condition that is independent of
          cardiovascular events, also increases the risk for MI. A case-control
          study was performed in 139 subjects with a history of MI and 287 control
          subjects selected from the Rotterdam Study, a population-based cohort of
          7983 subjects aged 55 years and older. The genotype of the -455G/A
          polymorphism in the fibrinogen beta-gene was determined by polymerase
          chain reaction. Functional plasma fibrinogen levels were determined
          according to von Clauss. The plasma level of fibrinogen was significantly
          higher in subjects with one or two A alleles compared with subjects with
          the GG genotype: 3.8 (95% confidence interval [CI], 3.6 to 3.9) g/L and
          3.6 (3.5 to 3.7) g/L, respectively. With increasing plasma fibrinogen
          level, the risk for MI increased gradually; a rise in fibrinogen of 1 g/L
          was associated with a 45% increased risk (odds ratio adjusted for age,
          sex, and smoking, 1.45; 95% CI, 1.12 to 1.88). There was no association
          between the genotype of the -455G/A polymorphism and the risk for MI. The
          -455G/A polymorphism is therefore associated with increased plasma
          fibrinogen levels but not with an increased risk for MI. These findings
          indicate that an increased plasma fibrinogen level due to this genetic
          factor does not increase the risk for MI.</description>
    </item> <item>
      <title>Haemostasis and cardiovascular disease (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/18021/</link>
      <pubDate>1997-04-02T00:00:00Z</pubDate>
      <description>The term 'coronary thrombosis' was derived from clinical and pathological observations
on myocardial infarction made at least 80 years ago' and perhaps even earlier.'·} It was
probably not until the 1930s that clinically manifest ischaemic heart disease in the form
of myocardial infarction became a familiar condition rather than the unusual occurrence
or even the rarity it had hitherto been. When the growing epidemic of clinical ischaemic
heart disease prompted an increasing and concerted research programme after the
Second World War, interest largely centred on the lipid nature of the atheromatous
plaque and the contributions dietary fat intake and blood cholesterol levels make to it.</description>
    </item>
  </channel>
</rss>